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ABSTRACT  
Human immunodeficiency virus type 1 (HIV-1) Vpu is an integral membrane protein that belongs 
to the viroporin family. Viroporins interact with cell membranes triggering membrane 
permeabilization and promoting release of viral particles. In vitro electrophysiological methods have 
revealed changes in membrane ion currents when Vpu is present, however, in vivo the molecular 
mechanism of Vpu at the plasma membrane is still uncertain. We used the yeast Saccharomyces 
cerevisiae as a genetic model system to analyze how Vpu ion channel impacts on cellular homeostasis. 
Inducible expression of Vpu impaired cell growth, suggesting that this viral protein is toxic to yeast 
cultures. This toxicity decreased with extracellular acidic pH. Also, Vpu toxicity diminished as 
extracellular K+ concentration was increased. However, expression of the Vpu protein suppresses 
the growth defect of K+ uptake-deficient yeast (Δtrk1,2). The phenotype rescue of these highly 
hyperpolarized cells was almost total when grown in medium supplemented with high 
concentrations of KCl (100 mM) and pH 7.0 but significantly reduced when extracellular K+ 
concentration or pH was decreased. These results indicate that Vpu has the ability to modify K+ 
transport in both yeast strains. Here, we show also that Vpu confers tolerance to the aminoglycoside 
antibiotic hygromycin B in Δtrk1,2 yeasts. Our results suggest that Vpu interferes with cell growth 
of wild-type yeast, but improves proliferation of hyperpolarized trk1,2 mutant by inducing plasma 
membrane depolarization.  
Furthermore, evaluation of ion channel activity of Vpu protein in Δtrk1,2 yeast could serve to 
develop a high-throughput screening assay for molecules that target the  
retroviral protein.    
The yeast Saccharomyces cerevisiae has been widely recognized as a model system for ion homeostasis 
studies of eukaryotic cells. Control of expression levels with inducible promoters and use of host strains 
with orthologous gene deletions facilitate functional studies with heterologous protein in yeast. In 
addition, alkali metal cation transport and homeostasis in yeast has been characterized in great detail. 
Depending on specific characteristics of the heterologous channel, phenotypic changes in host cells may 
vary widely. Fine analysis performed with M2 of Influenza virus, Kcv of PBCV-1 and PEDV  
 
ORF3 have proven the usefulness of the S. cerevisiae model for characterizing ion channel  
activity of viroporins (1-3).  
The Vpu protein of human immunodeficiency virus type 1 (HIV-1) is an oligomeric type I integral 
membrane protein (4;5). Vpu enhances release of virus particles by a still unclear mechanism (6). At 
present, when trying to explain the role that Vpu plays at this stage during virus replication cycle, two 
reported activities for the viral protein stand out. First, many studies report enhanced release of virus 
particles after Vpu antagonism with the IFN inducible factor tetherin (BST2) (7). A second approach 
focusses on similarities between Vpu and other small hydrophobic viral proteins (viroporins) that have 
been suggested to promote viral particle release by plasma membrane permeabilization (as reviewed in 
(8;9)).  Like other viroporins, Vpu associates with the plasma membrane permeabilizing it to non- 
permeating molecules (10;11). Evidence has been provided that Vpu oligomers form ion  
channels or pores in the plasma membrane (12;13). Besides Vpu, several other viroporins, including 
Influenza M2, HCV p7, PBCV-1 KcV and Coronavirus E protein among others,  
have membrane permeabilization activity and also ion channel capacity (14-17). However, these viroporin-
formed ion channels differ in the number of assembled-monomer units, subcellular localization and 
membrane topology (9). Early ex-vivo and in vivo studies demonstrated that Vpu forms cation-selective 
channels in lipid bilayers and also permeabilizes Escherichia coli plasma membrane to proline (18). 
Further studies performed in Xenopus oocytes suggested that Vpu ion channels are selective to 
monovalent cations  
over anions (19). NMR spectroscopy and computer simulations pointed to an homopentamer structure 
with some resemblance to  potassium channels and weak cation selectivity of Vpu channels (20-22). 5-(N,N-
hexamethylene) amiloride (HMA) blocks Vpu-induced cation currents in planar lipid bilayers and inhibits 
HIV-1 replication in macrophages (23;24). A novel inhibitor, BIT225, also inhibits the Vpu ion channel 
activity (25). Notably, Vpu- 
mediated tetherin antagonism is not affected by this viroporin inhibitor (26). In addition, ion channel 
activity and tetherin antagonism activities localize at different positions in the Vpu transmembrane 
domain (27).   
Vpu interacts with the mammalian TASK-1, a weak inward K+ rectifier and their  
 
interaction leads to mutual functional destruction (28). In lymphoid cells, Vpu inhibits TASK-1 conductance 
enhancing virus particle release. Besides, in the absence of Vpu, overexpression of the first 
transmembrane segment from TASK-1 causes a similar enhancing effect on the virus release. Further 
studies have demonstrated that  the efficiency of HIV-1 release is inversely correlated with membrane 
potential stability (29).  
Here we used S. cerevisiae as a genetic model to analyze the ion channel capacity of Vpu protein. We 
found functional complementation of K+-uptake mutant phenotypes by endogenously synthesized Vpu 
protein. Vpu complementation was dependent on extracellular pH and mediated by depolarization of 
the plasma membrane.   
EXPERIMENTAL PROCEDURES  
Plasmid construction and microbial strains. The vpu gene sequence from BH10 clone of HIV-1 (30) was 
cloned into the yeast expression vector pEMBLyex (31). Following standard procedures, viral sequence 
was inserted at BamHI and Hind III sites in the polylinker. The exogenous gene is controlled by the 
CYCGAL1 promoter which is tightly repressed by glucose and strongly induced by galactose. The E. coli 
DH5α strain (32) was used for the construction of  the  E.coli-yeast shuttle vector. Two S. cerevisiae strains 
were used, W303- 
1B  (33) and isogenic mutant WΔ3 (trk1::LEU2, trk2::HIS3) (34) that were generously provided by Dr. L. 
Carrasco (CBM. Universidad Autónoma de Madrid. Spain) and Dr. A. Rodríguez Navarro (ETSI Agrónomos. 
Universidad Politécnica de Madrid. Spain), respectively.  
Yeast media, transformation and induction. Yeast cells were grown at 30ºC, with orbital shaking at 300 
rpm, in standard YNB glucose medium supplemented with 20 mg/l Ltryptophan, 40 mg/l adenine (W303-
1B strain) or 20 mg/l (WΔ3 strain), and 20 mg/l Lhistidine (only W303-1B strain). For production of 
competent yeast and transformation, we used the standard lithium acetate protocol (35). Transformants 
of W303-1B strain were maintained on selective medium (containing 20 mg/l L-leucine). To achieve vpu 
expression, yeast cells were cultured in YNB medium containing 2% galactose and required supplements 
(inducing medium). To avoid extraneous cations in the growth media, we adjusted pH using arginine (36). 
When required, solid medium was prepared by the addition of 1.5 % purified agar (Difco) to the broth.  
Assay conditions. All experiments were independently repeated at least three times, using at least three 
cultures derived from independent colonies, with consistent results. Growth curves represent average 
data from three experiments. Before any experiments, cells were grown in non-inducing medium, 
adjusted to pH 6.5 with arginine, to the exponential phase. After washing with MilliQ water (36), cells were 
diluted in fresh inducing medium and cell density was properly adjusted. The cell growth was estimated 
by measuring optical density at 600 nm (OD600) (Genesys 10 VIS Thermo Scientific Spectrophotometer). 
Incubations were at 30 ºC, with shaking at 300 rpm. Mutant cells were grown in medium supplemented 
with 100 mM KCl to fulfill their K+ requirements. Liquid cultures were started with exponentially growing 
cells that were diluted in inducing medium to OD600 0.005  
(corresponding to 1.5 x 105 cells/ml). In growth kinetic assays, after 24 h of incubation (T= 0 h), samples 
were collected and OD600 was determined. Agar plate assays were performed with exponentially growing 
cells. After cell washing, cultures were diluted with fresh medium to OD600 0.2 (glucose) or 0.4 (galactose). 
 
Drop tests were performed by spotting 3 or 4 µl of serial dilutions of the cell suspension onto agar plates. 
These tests used the same (non-inducing or inducing) medium, adjusted to pH 7.0, to make dilutions and 
also prepare agar plates. Plates were incubated for indicated time at 30 ºC and then scanned.  
Statistical analysis. To compare growth differences between control and transfected cultures, scatter 
plots were created with data from replicated experiments. The growth phase was divided into two or 
three segments that were independently fitted to linear regression lines and slopes with correlation 
coefficient were calculated with the aid of  
Microsoft Excel.  
Protein extraction and Western blot. Exponentially growing cells were diluted in YNB (2% Galactose) to 
OD600 0.005 before incubation. When cultures reached OD600 1.0, 1 ml samples were collected for protein 
extraction using the following procedure.  Cells were pelleted and then resuspended in 1 ml lysis buffer 
[0.2 M NaOH (Merck), 0.1 M βmercaptoethanol (Merck) and 0.1 mM PMSF (Roche)]. After 5 min of 
incubation on ice, 2 µl of 100 % TCA were added and cell lysate was incubated at 65 ºC for 5 min and 
then incubated at 4 ºC for 5 min. The non-soluble fraction was collected by centrifugation and washed 
with acetone at -20 ºC (Merck). The pellet was speed-vac dried and then protein extract was resuspended 
in 100 µl sample buffer [0.16 M Tris-HCl pH 6.8 (Merck), 13.3 % glycerol (Merck), 2 % SDS (Serva), 1.5 % 
DTT (Sigma), 0.033 % bromophenol blue (Sigma)]. Finally, samples were sonicated and heated to 100 ºC 
for 5 min. Total protein content of each extract was assessed using Protein assay kit (Bio-Rad). All cellular 
extracts were adjusted to equal protein concentrations (1mg/ml), before loading onto a 20 % 
polyacrylamide gel for separating proteins by SDS- PAGE. After gel running, Vpu and PGK proteins were 
detected by Western blotting. Proteins were transferred to nitrocellulose membranes (Trans-blot 
Transfer Medium Bio-Rad) by wet blotting. The efficiency of protein transference was checked by staining 
proteins on the membrane using Ponceau S.  
Blots were quickly destained in distilled water and then incubated with a 1:5,000 dilution of Vpu 
polyclonal antibody (10) and PGK monoclonal antibody (Molecular Probes). After incubation with a 
1:10,000 dilution of a secondary peroxidase-conjugated goat (antirabbit/anti mouse) IgG antibody 
(Pierce), labelled proteins were detected using ECLTM Western Blotting Detection Reagents (Amersham). 
Blots were exposed to X-ray films to visualize chemiluminescence signal.  
Hygromycin B sensitivity. Changes in membrane potential in yeast plasma membrane were tested by 
measuring the entry of the antibiotic hygromycin B (Roche). Cells were grown to exponential phase and 
then washed with MilliQ water and resuspended in inducing medium, adjusted to pH 7.0 and 
supplemented with KCl 30 or 100 mM. Final cell density was adjusted to OD600 0.003. Increasing 
concentrations of hygromycin B were added to cells. After 45 or 48 h of incubation, the cellular density 
of each culture was determined by measuring the OD600. Relative growth was calculated as the ratio 
between growth in the presence and absence of added antibiotic and expressed as a percentage.  
RESULTS  
Inducible expression of Vpu protein in S. cerevisiae. Our initial rationale was that structural  
 
and functional similarities between yeast and human cell membranes (37;38) might help characterize in 
vivo how Vpu-plasma membrane interactions permeabilize cells. We used high copy plasmid, 
pEMBLyex4, to express Vpu in S. cerevisiae W303. Phosphoglycerate kinase (PGK), one of the most 
abundant proteins in the cell, enabled us to monitor the relative content of the viral protein. As shown 
in Fig. 1A, yeast growth in induction liquid medium yielded cells producing high levels of Vpu protein 
when bearing vpu-plasmid. Clones bearing vpu-plasmid or empty plasmid (control cells) were grown in 
solid minimal medium containing glucose and also in induction medium containing galactose (Fig. 1B). In 
glucose medium, both clones grew at the same levels. However, in induction medium, cells expressing 
vpu gene showed impaired growth relative to that of control cells. The growth defect of Vpu-expressing 
cells disappeared after longer incubation (data not shown); even so, the drop test documented growth 
differences of about a two-fold dilution.  
This finding suggests that HIV-1 Vpu exhibits deleterious effects on yeast cells but cultures can recover from 
such stress probably using their adaptive plasticity in response to changes in the ionic fluxes (39).  
Sensitivity to extracellular conditions. Some channels expressed in yeast are only functional  
over a narrow pH range (40). We assessed the growth characteristics on liquid cultures of both clones 
(bearing empty or vpu-plasmids) at various pHs (Fig. 2). Time course comparison of both transformants 
at pH 5.4 revealed a nearly indistinguishable growth pattern, although growth of vpu-expressing cells 
was slightly delayed. Thus, growth differences were shown from the beginning of the growing (slopes 
S1). At more neutral pHs, growth differences were more evident.  Thus, major differences in growth rates 
between both cultures were reached at pH 7.0. The highest rate of growth was reached by vpu-
expressing cells just after control cells shifted from fast to slow growth (pH 6.5 and 7). Western blot 
analysis, with PGK serving as a loading control, demonstrated that Vpu levels did not vary with pH of 
medium (data not shown). However, after longer adaptation periods as the pH became more neutral, 
vpu-expressing cultures reached the same growth as the control. These results suggested that vpu-
expression were unable to adapt to neutral pHout as well as control cells, indicating that deleterious effect 
of Vpu was pH-dependent.  
Having established that Vpu-induced growth impairment is modulated by extracellular pH, we were 
interested in investigating how Vpu protein may affect transport systems at the plasma membrane. 
Potassium is the major inorganic cation in the cell cytoplasm. Although yeast cells can grow in media 
with a wide range of extracellular potassium concentrations (low mM- μM), intracellular stores are 
always maintained around 200 to 300 mM by means of a mechanism of transport that may vary 
depending on the growth conditions (41). We analyzed Vpu effect when yeasts were cultured with varying 
potassium concentrations, by supplementing growth media with 10 or 100 mM KCl (Fig. 3). Both vpu-
expressing and control cultures reached faster growth rates with increasing potassium concentrations. 
However, under conditions of standard medium (7 mM K+) growth delay of vpu-expressing cells was very 
significant; they hardly reached the highest growth rate when control culture shifted to slower growth. 
When growth medium was supplemented with 10 mM KCl, growth of vpu-expressing yeast was also 
delayed, though the slope differences between both cultures were reduced. When growth medium was 
 
supplemented with 100 mM KCl, vpu expression slightly delay the early growth but cells recover rapidly 
from it and growth differences were almost indistinguishable between both transformants. These results 
suggest that the Vpu protein interferes with potassium uptake or its accumulation inside  
cells.   
Channel activity in K+-uptake defective cells. The conditional negative phenotype of Δtrk1,2 cells has 
been used to detect function of heterologous potassium channels by restoration of growth (40). 
Therefore, the auxotrophic double mutant strain, WΔ3, was used for phenotypic complementation 
studies, allowing us to specifically test for the K+ channel activity of Vpu. In this strain, the deletion of 
TRK1 and TRK2 transporters abolished highaffinity uptake of extracellular potassium, resulting in 
impaired cellular growth on potassium–limiting medium. We transfected the K+-uptake defective strain 
with control or vpu-containing plasmids. As shown in Fig. 4, when grown in the presence of galactose, 
high levels of Vpu protein were synthetized by cells transfected with plasmid containing the retroviral 
gene. Notably, these vpu-expressing cells grew to a greater extent than control cells. Drop test showed 
that both cultures differed by more than a two-fold dilution. These results revealed that Vpu can rescue 
the growth phenotype of Δtrk1,2. Vpu complementation with yeast Trk-system corroborated its ion 
permeation ability. Unfortunately, it was not possible to prove the capacity of HMA to inhibit this 
Vpuinduced growth enhancement; the intrinsic stimulation of yeast growth by the DMSO solvent was 
too high to permit reliable detection of growth differences induced by the dissolved drug (data not 
shown).  
Double mutant yeasts exhibit hypersensitivity to low extracellular pH that can be  
suppressed by the addition of high concentrations of potassium to the medium (42). We tested Vpu impact 
on growth behavior of mutant cells at different extracellular pHs ranging from 5.4 to 7.0 and in the 
presence of 100 mM KCl (Fig. 5). When grown at pH 5.4, mutant cells could hardly grow but a slight 
advantage of vpu-expressing culture was detected for early growth compared with control mutant. As 
pH increased, the Vpu-induced growth advantage became more pronounced. At pH 7.0, OD600 difference 
between both cultures reached 8.7 ± 0.35 fold (50h); in the absence of Vpu protein, the log-phase was 
delayed but Vpu endowed mutant cells with growth characteristics similar to those of isogenic wild-type 
cells (shown in Fig. 3). Thus, these observations demonstrated that Vpu restored the growth of K+ 
uptake–deficient cells.  
To gain further insights into the mechanism by which Vpu is involved in rescuing the mutant phenotype, 
potassium requirements for growth stimulation of Trk-deficient cells were tested (Fig. 6). Growth of 
mutant cells depended on the presence of high concentrations of extracellular K+ but Vpu endowed 
mutant cells with a growth advantage, even at low extracellular potassium (10 mM KCl). We observed 
that K+-uptake mutants exhibited growth defects. The final OD600 and growth slope of mutants are much 
smaller than isogenic wild type values (Fig. 3). However, under a non-limiting potassium concentration 
(100 mM KCl) Vpu protein shortened the lag-phase and increased growth yield of mutant strain, which 
now showed similar growth kinetics to those of the wild-type strain. These results indicated that Vpu 
protein was able to catalyze low-affinity K+ uptake.  
 
Impact of Vpu on low-affinity K+ transport. Similar ionic properties of potassium and ammonium permit, 
under limiting potassium concentrations, the entry of ammonium via potassium channels. Thus, 
ammonium inhibits K+ low-affinity uptake in Δtrk1,2 cells (34). In order to avoid any competitive 
ammonium inhibition, we used arginine as the unique nitrogen source during culture of transformed 
mutant cells (36). K+-uptake deficient cells grew to a lesser extent in ammonium-free medium than in 
ammonium containing medium (Fig. 7). Even though Vpu ameliorated potassium requirements in both 
media, differences in K+ requirements were much more appreciable in the absence of ammonium. This 
dramatic increase in tolerance to low K+ concentration indicates a possible competition between 
potassium and ammonium during Vpu-facilitated uptake.  
The knockout of both Trk potassium transporters has been reported to result in high membrane 
hyperpolarization leading to increased sensitivity to hygromycin B (34). We used the sensitivity towards 
this cationic antibiotic as an indirect indicator of plasma membrane potential of Δtrk1,2 transformants 
(Fig. 8). Under low K+ conditions (30 mM KCl) vpuexpressing cells exhibited high tolerance to 10 mg/ml 
hygromycin B in comparison with control cells. However, under near-physiological K+ conditions (100 
mM KCl), differences in hygromycin B tolerance between both transformants were significantly reduced. 
Thus, given that resistance to the positively charged aminoglycoside is closely correlated with a  
depolarization of the cellular membrane potential (43), the presence of Vpu protein should decrease the 
membrane potential of K+ uptake-deficient cells.  
DISCUSSION  
Vpu induces changes in composition and functioning of plasma membrane that may lead to  
the enhancement of virus particle release from the plasma membrane (29;44). This viroporin  
enhances even the release of unrelated viruses, such as Sindbis virus, Ebola Virus, etc (45;46). A debate is 
opened about the dual pore/ion channel functioning of Vpu viroporin during virus replication cycle (12;13). 
We previously demonstrated that HIV-1 Vpu enhances  
permeability of the plasma membrane in prokaryotic and mammalian cells (10). Here, transfected yeasts 
produce high levels of Vpu that result in growth impairment similar to that reported for the Influenza M2 
protein (2). Notably, the Influenza viroporin affected the transmembrane proton flux in wild type strain. 
Instead, we found that the HIV-1 viroporin modifies the potassium transport in both wild type and K+-
uptake mutant strains. Defective growth phenotype of trk1, trk2 null mutant cells is fully rescued by 
expressing the Vpu protein, in agreement with observations reported with other viroporin channels such 
as Kcv of PBCV-1 and PEDV ORF3 (1;3).  
Vpu protein complements the potassium uptake deficient phenotype in a pHout dependent manner. This 
behavior is similar to that reported for mouse inward K+ rectifying channel, Kir2.1 (47). In yeast, Trk1 and 
Trk2 are involved in the response of the membrane potential  
 
to changes in the external pH, increasing the permeability to H+ (34). This may be the reason why pH-
dependence of Vpu activity was stronger in the defective mutant than in the wildtype strain. The K+ 
uptake complementation by Vpu is more evident in the absence of ammonium than when present. This 
suggests that Vpu may function as a non-specific cation channel with inward transport of K+ and also 
ammonium ions.  
The knockout of both Trk potassium transporters has been reported to result in high plasma membrane 
hyperpolarization (34). At extracellular pH 7 and high potassium concentration, Vpu-expressing mutants 
grow even better than non-expressing wild-type cells in conditions of K+ restriction, but not control 
mutants. The Vpu-induced restoration of growth phenotype in mutant cells suggested a restoration of 
membrane potential as a result of increased inward transport of ectopic potassium. Wild type yeasts are 
sensitive to hygromycin B and become resistant to the drug by defects in the plasma membrane 
H+ATPase, that result in membrane depolarization (43). Thus, the hyperpolarized tkr1Δtkr2Δ  
strain is hypersensitive to hygromycin B (34). Notably, our results show that Vpu confers hygromycin B 
resistance to the hypersensitive tkr1Δtkr2Δ strain. This evidence suggests a depolarizing role for the Vpu 
protein in eukaryotic cells. Our results suggest that Vpu interferes with the signaling regulation of 
potassium transport (48). It is possible that depolarization by Vpu protein destabilizes Trk system at the 
plasma membrane. Thus, under low K+ conditions Vpu would interfere with potassium homeostasis by 
accelerating the turnover of essential transporters.   
Taken together, these data support a model in which Vpu depolarizes plasma membrane by forming 
channels with weak selectivity for K+. The ion channel activity of Vpu should affect functioning of cellular 
channels involved with ion homeostasis and eventual membrane disturbance. In fact, recent studies in 
human cells showed that vesicle release  
was promoted as a result of silencing K2P channels (49). Similarly, Vpu channel may depolarize the budding 
membrane, making particle release an energetically favorable process, as previously proposed. Thus, our 
results are compatible with suggested changes in composition and functioning of plasma membrane that 
may lead to the Vpu-induced  
enhancement of virus particle release from the plasma membrane (29;44).  
Contrary to most studies, which have used the transmembrane domain of Vpu or a fusion protein 
including full sequence, here we used genuine Vpu protein already synthetized in a cellular system. 
Although other models could just show a slight cation preference of Vpu channels, here we specifically 
demonstrate that Vpu modifies K+ transport through plasma membrane. Owing to its good phenotype 
complementation, trk1 trk2 null mutants of S. cerevisiae represent a promising model for screening of 
inhibitors of channel-forming Vpu protein and also other viroporins.   
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FIGURE LEGENDS  
Figure 1. Growth impairment of cells expressing vpu gene. Cells, transformed with control plasmid (-) or 
vpu-plasmid (+), were inoculated into glucose or galactose containing medium. A) Yeasts were grown in 
liquid media with vigorous aeration. Expression levels of Vpu protein were analyzed in each culture by 
Western blot, using PGK or Vpu antibodies. B) Drop test analysis with series of two-fold dilutions. Before 
digitally scanned, plates were incubated for 2 (glucose) or 3 (galactose) days.   
Figure 2. pHout sensitivity of the Vpu activity in S. cerevisiae. Cells were grown in inducing media adjusted 
with arginine to the corresponding pH. OD600 was measured at indicated times. Control (■) and Vpu (□). 
Growth curves represent the average of three independent experiments with error bars indicating 
standard deviation (mean ± SD). Linear regression lines were fitted to the replicate data included into 
two or three segments indicated with arrows in each curve.  S1, S2 and S3 indicate the corresponding 
values obtained for slope (R2) of the early (1), middle (2) and late (3) segments respectively.   
Figure 3. Extracellular K+ concentration dependency of growth impairment by Vpu protein. Cells, 
transformed with control or vpu-plasmid, were grown in inducing media adjusted to pH 7.0 and 
containing different K+ concentrations. The OD 600 is plotted versus time (in hours). Control (■) and Vpu 
(□). Growth curves represent the average of three independent experiments with error bars indicating 
standard deviation (mean ± SD). Linear regression lines were fitted to data included into two or three 
segments indicated with arrows in each curve.  S1, S2 and S3 indicate the corresponding values obtained 
for slope (R2) of the early  
(1), middle (2) and late (3) segments respectively.  
Figure 4. Complementation of growth defect by vpu expression in a Δtrk1 Δtrk2 yeast mutant. Cells, 
transformed with control (-) or vpu-plasmid (+) were inoculated into glucose or galactose medium, 
supplemented with 100 mM KCl. A) Cells were grown in liquid media with vigorous aeration. Western 
blot used PGK or Vpu antibodies. B) Drop test analysis of serial two-fold dilutions. Before digitally 
scanned, plates were incubated for 2 (glucose) or 3 (galactose) days.  
 Figure 5. Acid sensitivity of Vpu channel activity. Δtrk1 Δtrk2 cells were grown in inducing media, 
supplemented with KCl 100 mM and adjusted with arginine to appropriated pHs. OD600 was measured at 
indicated times. Control (■) and Vpu (□).  
Growth curves represent the average of three independent experiments with error bars indicating 
standard deviation (mean ± SD). Linear regression lines were fitted to data included into two segments 
indicated with arrows in each curve.  S1, S2 and S3 indicate the corresponding values obtained for slope 
(R2) of the early (1), middle (2) and late (3) segments respectively.  
Figure 6. Modulation of Vpu phenotype complementation in trk1,trk2 null mutants by extracellular K+ 
concentration. Δtrk1 Δtrk2 cells, transformed with control or vpu-plasmids, were grown in inducing 
media adjusted to pH 7.0 and containing different K+ concentrations. The OD 600 is plotted versus time 
(in hours). Control (■) and Vpu (□). Growth curves represent the average of three independent 
experiments with error bars indicating standard deviation (mean ± SD). Linear regression lines were fitted 
 
to data included into two segments indicated with arrows in each curve.  S1 and S2 indicate the 
corresponding values obtained for slope (R2) of the early (1), middle (2) and late (3) segments 
respectively.  
Figure 7. Influence of type of nitrogen source on the release from potassium requirements of mutants 
by Vpu channel. Δtrk1 Δtrk2 cells, transformed with control or vpu-plasmids, were suspended in standard 
medium (+NH4+) and also in modified medium (-NH4+); both media adjusted to pH 7.0. Drop test analysis 
with series of 5-fold dilutions. Before digitally scanned, plates were incubated for 5 (+NH4+) or 8 (-NH4+) 
days.  
Figure 8. Influence of Vpu protein on the Hygromycin B sensitivity of trk1,trk2 null mutants. Control cells 
(black) and Vpu cells (white) were grown in the presence of increasing hygromycin B concentrations 
(μg/ml). Drug sensitivity was tested using induction medium supplemented 30 or 100 mM KCl. OD600 was 
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